Case Report

A Case of Rituximab-Induced Necrotizing Fasciitis and a Review of the Literature

Table 1

Cases of patients developing NF after rituximab therapy.

S/NStudyConditionAge/sexDosing protocolCycle,
dose
Onset of NF from last doseOrganismLocation
of NF
Concurrent
medication
ComorbiditiesOutcome

1Current studyCLL69/M375 mg/m2 ×42, 47 weeksClostridium septicumLLENoneNoneSurvived

2Lazzeri et al. [9, 10]CLL44/MNANANAPseudomonas aeruginosaPeriorbitalFludarabine
Cyclophosphamide
NASurvived

3Guerrero et al. [11]; Wong et al. [12]SLE21/MNANANAAcinetobacter baumanniiAbdomen
Bil flanks
Thigh
Scapula
SteroidsNADied

4Krieger et al. [13]NHL, follicular48/F375 mg/m2
(weekly)
1, 41 monthPseudomonas aeruginosaLeft lower
extremity
NANADied

5Krieger et al. [13]NHL, follicular59/M375 mg/m2 (weekly)
Rituximab stopped after 3 doses.
1, 3NAEscherichia coli (E. coli)ScrotumEtoposide, cisplatin, methyl prednisone, cytosine, and arabinosideNADied

6Looney et al. [14]SLE37/F375 mg/m2 ×4
(weekly)
1, 46 weeksGroup A StreptococcusElbowMethotrexate
Steroids
Septic arthritisN/A

7Chen and Isenberg [15]SLE26/F1 g weekly1, 22 monthsPseudomonas aeroginosaLLEHydroxychloroquine
Azathioprine
Cyclophosphamide
Steroid
AVN below
Digital ischemia
E. coli UTI
Survived

8Morita et al. [16]Waldenstrom’s macroglobulinemia76/M375 mg/m2
(weekly)
1, 12 weeksKlebsiella pneumoniaRLEBortezomib
Dexamethasone
DiarrheaDied

9Raghuvanshi and Menon [17]Rheumatoid arthritis62/FNA1, 22 weeksGroup A StreptococcusLUEPrednisoneNADied

AVN = avascular necrosis; Bil = bilateral; CLL = chronic lymphocytic leukemia; F = female; LLE = left lower extremity; LUE = left upper extremity; M = male; NA = not available; NF = necrotizing fasciitis; NHL = non-Hodgkin’s lymphoma; RLE = right lower extremity; SLE = systemic lupus erythematosus; S/N = serial number; UTI = urinary tract infection.